4 min read

EverHint – Crossovers Pack – Top 11 Buy and Top 10 Sell Signals for Sep 24, 2026

21 signals (from 104 total). Technology leads (18). price range $3-$1279. 2 with insider buying. 4 with insider selling.

Excerpt: 21 signals (from 104 total). Technology leads (18). price range $3-$1279. 2 with insider buying. 4 with insider selling.

Market Context

The major indices are trading in a narrow, mixed range — the S&P 500 and Dow Jones posting fractional declines while the Nasdaq holds essentially flat — signaling a market in consolidation rather than directional conviction. This kind of tight price action can create noise for momentum-based signals like EMA 10 + Price + MACD, where small intraday swings may trigger entries without sufficient follow-through. Traders relying on these signals should be mindful of potential false breakouts in this low-momentum environment.

The VIX reading of 15.67, up over 3% on the day, is worth watching closely. While still within a historically moderate range, the intraday spike in implied volatility suggests that uncertainty is quietly building beneath an otherwise calm surface. For crossover strategies like SMA 20/50 and EMA 10/30, rising volatility can compress the time between signal generation and invalidation, increasing the likelihood of whipsaw conditions — particularly in shorter timeframes where price can breach moving averages and reverse quickly.

Technology's dominance as the top sector aligns with the Nasdaq's relative outperformance versus the broader market, suggesting that risk appetite, while cautious, remains tilted toward growth-oriented assets. This sector leadership supports the relevance of trend-following signals in tech-heavy segments, as momentum tends to be more sustained when a sector is attracting consistent capital rotation. However, with the Dow's underperformance hinting at some rotation away from value and cyclical names, signal quality may vary significantly depending on which segment of the market a given strategy is targeting.

EMA 10 + Price + MACD

Experimental strategy combining price crossing above EMA10 from below with MACD Line crossing above Signal Line from below. Both conditions must occur on the same day for a signal, providing double confirmation and higher-quality setups.

Entry Criteria:

  • Buy: Price > EMA10 AND MACD line crosses above signal line
  • Sell: Price < EMA10 AND MACD line crosses below signal line
  • Minimum ADV: $40M (liquidity filter)
  • Earnings buffer: 7 days pre/post earnings
  • Fresh signal: All conditions met on today's close

Holding period: 1-3 weeks | Risk level: Medium-High

🟢 Buy Signals (5 of 8)

Ranked by RSI (lower RSI = more oversold for buy signals)

# Ticker Company Sector Price Insider MCap
1 GWW W.W. Grainger, Inc. Industrials $1279.47 — $60.4B
2 H Hyatt Hotels Corporation Consumer Cyclical $159.03 — $15.1B
3 ICLR ICON Public Limited Co... Healthcare $173.90 Sell -$1,445,500 $13.3B
4 KOD Kodiak Sciences Inc. Healthcare $33.22 — $2.1B
5 LEGN Legend Biotech Corpora... Healthcare $19.06 — $3.5B

Insider selling (7d): ICLR (-$1,445,500)

SMA 20/50 Crossover

Detects fresh crossovers between the 20-day simple moving average (SMA20) and the 50-day simple moving average (SMA50). Uses two SMAs, making it more stable and less prone to false signals compared to EMA-based strategies. Well-suited for identifying medium-term trend changes with higher reliability.

Entry Criteria:

  • Buy: SMA20 crosses above SMA50
  • Sell: SMA20 crosses below SMA50
  • Minimum ADV: $40M (liquidity filter)
  • Earnings buffer: 7 days pre/post earnings
  • Fresh crossover: Detected on today's close

Holding period: 2-6 weeks | Risk level: Medium

🟢 Buy Signals (1 of 1)

Ranked by RSI (lower RSI = more oversold for buy signals)

# Ticker Company Sector Price Insider MCap
1 TENB Tenable Holdings, Inc. Technology $35.88 — $4.0B

🔴 Sell Signals (5 of 32)

# Ticker Company Sector Price Insider MCap
1 ACAD ACADIA Pharmaceuticals... Healthcare $22.18 — $3.8B
2 AIZ Assurant, Inc. Financial Services $261.89 — $13.0B
3 AMP Ameriprise Financial, ... Financial Services $485.15 — $43.6B
4 ASH Ashland Inc. Basic Materials $69.10 — $3.2B
5 AVY Avery Dennison Corpora... Consumer Cyclical $169.01 — $12.9B

EMA 10/30 Crossover

Detects fresh crossovers between the 10-day exponential moving average (EMA10) and the 30-day exponential moving average (EMA30), generating both buy and sell signals. Uses two EMAs instead of EMA + SMA, making it more responsive to price changes and better suited for capturing short-to-medium term momentum shifts.

Entry Criteria:

  • Buy: EMA10 crosses above EMA30
  • Sell: EMA10 crosses below EMA30
  • Minimum ADV: $40M (liquidity filter)
  • Earnings buffer: 7 days pre/post earnings
  • Fresh crossover: Detected on today's close

Holding period: 1-4 weeks | Risk level: Medium

🟢 Buy Signals (5 of 15)

Ranked by RSI (lower RSI for buy signals = more oversold)

# Ticker Company Sector Price Insider MCap
1 AMG Affiliated Managers Gr... Financial Services $370.71 — $9.8B
2 BB BlackBerry Limited Technology $8.73 — $5.1B
3 CNK Cinemark Holdings, Inc. Communication Services $36.98 — $4.3B
4 DGII Digi International Inc. Technology $76.75 — $2.9B
5 EMR Emerson Electric Co. Industrials $156.08 — $87.4B

🔴 Sell Signals (5 of 48)

# Ticker Company Sector Price Insider MCap
1 ABEV Ambev S.A. Consumer Defensive $2.92 — $45.0B
2 AG First Majestic Silver ... Basic Materials $18.76 — $9.2B
3 AGIO Agios Pharmaceuticals,... Healthcare $32.90 — $2.0B
4 ALG Alamo Group Inc. Industrials $159.02 — $1.9B
5 AMT American Tower Corpora... Real Estate $167.26 — $77.9B

Field Notes

Sector concentration: Technology (18), Healthcare (17), Financial Services (17)

Insider selling (7d): ICLR (ICON Public Limited Company, -$1,445,500)

Data coverage: 5.8% insider (7d), 0.0% congressional (30d), 0.0% earnings, 2.9% news (7d)

Vlad's Take

Today's signals: Strong sector concentration in Technology (18 signals) suggests sector-specific rotation. 2 signals with insider buying adds conviction. 4 signals showing insider selling warrant caution.


Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/

📢 Enjoying the updates? Liking, sharing, or subscribing helps bring this analysis to a wider audience.